This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Advisory Committee on Dangerous Pathogens. (1996). Management and control of viral haemorrhagic fevers. http://www.hpa.org.uk/infections/topics_az/VHF/ACDP_VHF_guidance.pdf.
Baize, S. (2005). A single shot against Ebola and Marburg virus. Nat Med 11:720–1.
Baize, S., Marianneau, P., Georges-Courbot, M.C. and Deubel, V. (2001). Recent advances in vaccines against viral haemorrhagic fevers. Curr Opin Infect Dis 14:513–8.
Borio, L., Inglesby, T., Peters, C.J., Schmaljohn, A.L., Hughes, J.M., Jahrling, P.B., Ksiazek, T., Johnson, K.M., Meyerhoff, A., O’toole, T., Ascher, M.S., Bartlett, J., Breman, J.G., Eitzen, E.M., Jr., Hamburg, M., Hauer, J., Henderson, D.A., Johnson, R.T., Kwik, G., Layton, M., Lillibridge, S., Nabel, G.J., Osterholm, M.T., Perl, T.M., Russell, P. and Tonat, K. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management. Jama 287:2391–405.
Centers for Disease Control and Prevention (2005a). http://www.bt.cdc.gov/agent/vhf/index.asp.
Centers for Disease Control and Prevention (2005b). http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm.
Centers for Disease Control and Prevention (2005c). http://www.cdc.gov/ncidod/dvrd/spb/mnpages/vhfmanual.htm.
Eurosurveillance (2002). http://www.eurosurveillance.org/em/v07n03/v07n03.pdf.
Eurosurveillance (2004). http://www.eurosurveillance.org/em/v09n12/0912-235.pdf.
Feldmann, H., Jones, S., Klenk, H.D. and Schnittler, H.J. (2003). Ebola virus: from discovery to vaccine. Nat Rev Immunol 3:677–85.
Fisher-Hoch, S.P. and Mccormick, J.B. (2004). Lassa fever vaccine. Expert Rev Vaccines 3:189–97.
Geisbert, T.W. and Hensley, L.E. (2004). Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 6:1–24.
Geisbert, T.W. and Jahrling, P.B. (2004). Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110–21.
Health Protection Agency (2005a). http://www.hpa.org.uk/infections/topics_az/deliberate_release/VHF/homepage.asp.
Health Protection Agency (2005b). http://www.hpa.org.uk/infections/topics_az/VHF/menu.htm.
Jones, S.M., Feldmann, H., Stroher, U., Geisbert, J.B., Fernando, L., Grolla, A., Klenk, H.D., Sullivan, N.J., Volchkov, V.E., Fritz, E.A., Daddario, K.M., Hensley, L.E., Jahrling, P.B. and Geisbert, T.W. (2005). Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11:786–90.
Klietmann, W.F. and Ruoff, K.L. (2001). Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev 14:364–81.
Lowenstein, R. (2004). Deadly viral syndrome mimics. Emerg Med Clin North Am 22:1051–65, ix–x.
Mahanty, S. and Bray, M. (2004). Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4:487–98.
Mccormick, J.B., King, I.J., Webb, P.A., Johnson, K.M., O’sullivan, R., Smith, E.S., Trippel, S. and Tong, T.C. (1987). A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445–55.
Mccormick, J.B., King, I.J., Webb, P.A., Scribner, C.L., Craven, R.B., Johnson, K.M., Elliott, L.H. and Belmont-Williams, R. (1986). Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20–6.
Ndayimirije, N. and Kindhauser, M.K. (2005). Marburg hemorrhagic fever in Angola-fighting fear and a lethal pathogen. N Engl J Med 352:2155–7.
Peters, C.J. (2005). Marburg and Ebola-arming ourselves against the deadly filoviruses. N Engl J Med 352:2571–3.
Richmond, J.K. and Baglole, D.J. (2003). Lassa fever: epidemiology, clinical features, and social consequences. Bmj 327:1271–5.
Salvaggio, M.R. and Baddley, J.W. (2004). Other viral bioweapons: Ebola and Marburg hemorrhagic fever. Dermatol Clin 22:291–302, vi.
Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. and Nabel, G.J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature 408:605–9.
World Health Organization (2005a). http://www.who.int/csr/disease/en/.
World Health Organization (2005b). http://www.who.int/topics/haemorrhagic_fevers_viral/en/.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Curtis, N. (2006). Viral Haemorrhagic Fevers Caused by Lassa, Ebola and Marburg Viruses. In: Pollard, A.J., Finn, A. (eds) Hot Topics in Infection and Immunity in Children III. Advances in Experimental Medicine and Biology, vol 582. Springer, Boston, MA . https://doi.org/10.1007/0-387-33026-7_4
Download citation
DOI: https://doi.org/10.1007/0-387-33026-7_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31783-0
Online ISBN: 978-0-387-33026-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)